Browsing by Author "Johansen, Tonje Okkenhaug"

Now showing items 1-5 of 5

    • Long-Term Results After Surgery for Degenerative Cervical Myelopathy 

      Johansen, Tonje Okkenhaug; Holmberg, Siril Therese; Danielsen, Elisabet; Rao, Vidar; Salvesen, Øyvind Olav; Andresen, Hege; Carmen, Vleggeert-Lankamp; Solberg, Tore; Gulati, Sasha; Nygaard, Øystein Petter (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-10-20)
      BACKGROUND AND OBJECTIVES: Degenerative cervical myelopathy (DCM) is a frequent cause of spinal cord dysfunction, and surgical treatment is considered safe and effective. Long-term results after surgery are limited. This study investigated long-term clinical outcomes through data from the Norwegian registry for spine surgery.<p> <p>METHODS: Patients operated at the university hospitals serving ...

    • Surgery for degenerative cervical myelopathy in patients with rheumatoid arthritis and ankylosing spondylitis: a nationwide registry-based study with patient-reported outcomes 

      Holmberg, Siril Therese; Gulati, Agnete Malm; Johansen, Tonje Okkenhaug; Salvesen, Øyvind; Vangen-Lønne, Vetle; Solberg, Tore; Tronvik, Erling Andreas; Nygaard, Øystein Petter; Gulati, Sasha (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-10-15)
      Purpose To compare patient-reported outcomes (PROMs) following surgery for degenerative cervical myelopathy (DCM) among patients with rheumatoid arthritis (RA) or ankylosing spondylitis (AS) versus those without rheumatic diseases. Methods Data were obtained from the Norwegian Registry for Spine Surgery. The primary outcome was change in the Neck Disability Index (NDI) at 1 year. Secondary endpoints ...

    • Surgery for degenerative cervical myelopathy in the elderly: a nationwide registry-based observational study with patient-reported outcomes 

      Johansen, Tonje Okkenhaug; Vangen-Lønne, Vetle; Holmberg, Siril Therese; Salvesen, Øyvind; Solberg, Tore; Gulati, Agnete Malm; Nygaard, Øystein Petter; Gulati, Sasha (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-07-19)
      Background - The aim of this study was to investigate whether clinical outcomes in patients aged ≥ 70 undergoing decompressive surgery for degenerative cervical myelopathy (DCM) differ from those of younger patients (50–70 years) at 1 year.<p> <p>Methods - Data were obtained from the Norwegian Registry for Spine Surgery (NORspine). Among 651 patients included, 177 (27.2%) were ≥ 70 years old. The ...

    • Surgery for Degenerative Cervical Myelopathy: A Nationwide Registry-Based Observational Study With Patient-Reported Outcomes 

      Gulati, Sasha; Vangen-Lønne, Vetle; Nygaard, Øystein Petter; Gulati, Agnete Malm; Hammer, Tommy; Johansen, Tonje Okkenhaug; Peul, Wilco C.; Salvesen, Øyvind; Solberg, Tore (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-07-29)
      Background: Indications and optimal timing for surgical treatment of degenerative cervical myelopathy (DCM) remain unclear, and data from daily clinical practice are warranted.<p> <p>Objective: To investigate clinical outcomes following decompressive surgery for DCM. Methods: Data were obtained from the Norwegian Registry for Spine Surgery. The primary outcome was change in the neck disability index ...

    • Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series 

      Wiedmann, Markus; Skattør, Thor Håkon; Stray-Pedersen, Arne; Romundstad, Luis Georg; Antal, Ellen-Ann; Marthinsen, Pål Bache; Sørvoll, Ingvild Hausberg; Ernstsen, Siw Leiknes; Lund, Christian G.; Holme, Pål Andre; Johansen, Tonje Okkenhaug; Brunborg, Cathrine; Aamodt, Anne Hege; Schultz, Nina Haagenrud; Skagen, Karolina Ryeng; Skjelland, Mona Elisabeth (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-07-30)
      During a 2-week period, we have encountered five cases presenting with the combination of cerebral venous thrombosis (CVT), intracerebral hemorrhage and thrombocytopenia. A clinical hallmark was the rapid and severe progression of disease in spite of maximum treatment efforts, resulting in fatal outcome in for 4 out of 5 patients. All cases had received ChAdOx1 nCov-19 vaccine 1–2 weeks earlier and ...